Mylan to buy Swedish drugmaker Meda in $9.9 billion deal
February 10, 2016 at 16:50 PM EST
(Reuters) - Generic drugmaker Mylan NV said it would buy Sweden's Meda AB in a deal valued at $9.9 billion, including debt.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.